Assertio operates as a lean commercial pharmaceutical enterprise following corporate restructuring and its subsequent acquisition by Zydus Lifesciences. Official corporate filings and market intelligence data indicate that the company maintains a highly streamlined core team ranging between 50 to 65 professional employees based primarily in the United States. This compact headcount handles executive leadership, digital marketing, strategic portfolio management, and regulatory compliance while outsourcing heavy manufacturing and laboratory research functions.